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Signal transducer and activator of transcription-3 (STAT3) regulates inflammation,
apoptosis, and protease expression, which are critical processes associated with airway
injury and lung tissue destruction. However, the precise role of STAT3 in the development
of airway diseases such as chronic obstructive pulmonary disease (COPD) has not
been established. This study shows that cigarette smoke activates STAT3 in the lungs
of mice. Since cigarette smoke activated STAT3 in the lung, we then evaluated how
the loss of STAT3 would impact on smoke-mediated lung inflammation, protease
expression, and apoptosis. STAT3+/+ and STAT3−/− mice were exposed to 8 days of
cigarette smoke. Compared to the STAT3+/+ mice bronchoalveolar lavage fluid (BALF)
cellularity was significantly elevated in the STAT3−/− mice both before and after cigarette
smoke exposure, with the increase in cells primarily macrophages. In addition, smoke
exposure induced significantly higher BALF protein levels of Interleukin-1α (IL-1α), and
monocyte chemotactic protein-1 (MCP-1) and higher tissue expression of keratinocyte
chemoattractant (KC) in the STAT3−/− mice. Lung mRNA expression of MMP-12 was
increased in STAT3−/− at baseline. However, the smoke-induced increase in MMP-10
expression seen in the STAT3+/+ mice was not observed in the STAT3−/− mice. Moreover,
lung protein levels of the anti-inflammatory proteins SOCS3 and IL-10 were markedly
lower in the STAT3−/− mice compared to the STAT3+/+ mice. Lastly, apoptosis, as
determined by caspase 3/7 activity assay, was increased in the STAT3−/− at baseline to
levels comparable to those observed in the smoke-exposed STAT3+/+ mice. Together,
these results indicate that the smoke-mediated induction of lung STAT3 activity may play
a critical role in maintaining normal lung homeostasis and function.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is now the third
leading cause of death in the United States (Murphy et al., 2012)
and it is projected to become the third leading cause worldwide
within the next 20 years (Raherison and Girodet, 2009). In con-
trast to other diseases, the age-adjusted mortality for COPD has
increased over the past 30 years (Miller et al., 2000). Current
pharmacological therapies improve lung function and slow dis-
ease progression but they have not been shown to impact on
COPD mortality (Kim and Criner, 2013). Cigarette smoke is the
major etiologic factor associated with this disorder and prolonged
exposure to cigarette smoke induces damaging inflammatory,
apoptotic, and proteolytic responses in the lung (Macnee, 2007).
These biological processes lead to dysfunctional matrix remod-
eling that cause airway obstruction and lung tissue destruction
(Cornwell et al., 2010). A better understanding of the varied sig-
naling processes that mediate the loss of normal airway function
is needed to more effectively address the underlying mechanisms
of this disease.
Signal transducer and activator of transcription 3 (STAT3)
is a transcription factor that mediates IL-6 signaling responses.
Upon binding to the gp130 receptor, IL-6 activates Janus kinases
(JAKs), which phosphorylate STAT3 thereby inducing its nuclear
translocation and transcriptional activation. In addition to IL-
6 signaling, STAT3 can be activated by EGFR, PDGFR, and Src
kinase. Once activated, STAT3 binds the enhancer element in
the promoter region of acute-phase genes, known as the acute-
phase response element (Gerhartz et al., 1996) and induces the
expression of numerous pro-inflammatory genes in the lung
(Saleh et al., 2009). STAT3 was recently shown to be required for
the development of allergic inflammation in a mouse model of
asthma (Simeone-Penney et al., 2007). Indeed, the loss of STAT3
expression within the airway epithelium decreased the expression
of Th2 cytokines, lowered airway inflammation and prevented
the development of airway hyperreactivity in an asthma model
(Simeone-Penney et al., 2007). Conversely, transgenic expres-
sion of STAT3 within the alveolar epithelium of mice markedly
induced cytokine expression and lung inflammation (Gobburu
et al., 1998). Given these findings, STAT3 activation is believed
to be a central factor in the induction of airway inflammatory
responses. Nevertheless, the role of STAT3 in airway diseases
remains to be determined.
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Though STAT3 affects key disease processes, data on the
effect of STAT3 in COPD is lacking. Upregulation of STAT3
and induction of genes associated with STAT3 expression have
been documented in lung tissue samples from COPD patients
(Qu et al., 2009). Since STAT3 expression is increased in
COPD, our study examined how cigarette smoke exposure
impacted on STAT3 activation in the lungs of mice over the
course of 1 year. In addition, we utilized the cigarette smoke
exposure model to determine how STAT3 directly affected
key biological processes implicated in the development of
COPD. To examine this, STAT3+/+ and STAT3−/− mice were
exposed to cigarette smoke in order to assess how the loss of
STAT3 impacted on lung inflammation, apoptosis and protease
expression.
METHODS
ANIMAL MODELS
Three-month old 129X1-Stat3tm1Desi/J (STAT3−/−) and
129X1/SvJ controls (STAT3+/+) (Jackson Labs, Bar Harbor,
ME) were used for these studies. The 129X1-Stat3tm1Desi/J mice
have a mutant β isoform of STAT3 and only express the α
isoform. C57Bl/6J mice (Jackson Labs) were used to kinetically
examine the effects of cigarette exposure (from 1 day to 1 year of
smoke exposure) on STAT3 activity in lung protein. All animal
experiments were performed with approval from St. Luke’s
Roosevelt’s Hospital Center’s Institutional Animal Care and Use
Committee approval.
CIGARETTE SMOKE EXPOSURE PROTOCOL
In accordance with our previously published protocol (Geraghty
et al., 2013), mice were exposed to cigarette smoke from 3R4F
research cigarettes (University of Kentucky, Lexington, KY) in
a specially designed whole body smoking apparatus (Teague
Enterprises, Davis, CA) for 4 h a day at a total particulate mat-
ter concentration of 80mg/m3. The mice had access to food and
water and were able to move about freely during the period of
smoke exposure. The mice were euthanized and bronchoalveolar
lavage fluid (BALF) and lung tissue was collected 12 h following
the last cigarette smoke exposure.
qPCR
mRNAwas isolated from lung tissue of room air and 8-day smoke
exposed STAT3+/+ and STAT3−/− mice using Trizol reagent
(Life Technologies, Grand Island, NY). cDNA was prepared from
this mRNA using Superscript (Life Technologies). Lung expres-
sion of Cathepsin S, Cathepsin K, matrix metalloproteinase-3
(MMP-3), MMP-7, MMP-8, MMP-9, MMP-10, MMP-12, MMP-
13, tumor necrosis factor-α (TNF-α), IL-1β, IL-17, CD68, and KC
was assessed by quantitative PCR using Taqman specific probes
(Applied Biosystems, Grand Island, NY). Analyzed changes in
gene expression in samples were related to another reference sam-
ple, usually room air treated STAT3+/+ mice where the reference
sample is set to 1.
PROTEASE AND CYTOKINE MEASUREMENTS
IL-1α, IL-6, IL-10, IL-13, IL-17, IFN-γ, MCP-1, RANTES
(Regulated on Activation,Normal T cell Expressed and Secreted),
and TNF-α were measured in BALF using a beads assay on the
BioRad Bio-Plex 200 system (BioRad, Hercules, CA).
INTRACELLULAR SIGNALING
Lung tissue was subfractionated into cytosolic and nuclear frac-
tions using a commercially available protein compartment kit
(Millipore, Billerica, MA). Immunoblots were conducted on the
cytosolic protein to assess levels of phospho-B cell lymphoma-
2 protein (p-Bcl-2), Bcl-2, suppressor of cytokine signaling3
(SOCS3) and actin (all antibodies from Cell Signaling, Danvers,
MA). The proteins were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis and then transferred to a
nitrocellulose membrane. After blocking for 1 h with 5% milk
protein (BioRad, Hercules, CA), the membranes were incubated
for 1 h at room temperature with a 1:1000 dilution of primary
antibody (p-Bcl2ser70 #2827, Bcl2 #2876, SOCS3 #2932, Actin
#4967) in 2.5% bovine serum albumin (BSA). After washing,
the membranes were then incubated with a 1:4000 dilution of
horseradish peroxidase linked secondary antibody (#7074) in
FIGURE 1 | Cigarette smoke exposure induces STAT3 activation in the
lungs of exposed mice. (A) Three-month old C57Bl/6J mice were exposed
to cigarette smoke for 1 day, 8 days, 7 weeks, and 1 year. Nuclear protein
fractions were prepared from the lung tissue and STAT3 activity was
measured using a specific oligonucleotide-binding assay. (B) Lung nuclear
proteins were examined for STAT3 activity from 129X1-Stat3tm1Desi /J
(STAT3−/−) and 129X1/SvJ controls (STAT3+/+) mice after 8 days of either
room air or cigarette smoke exposure. Data are reported as STAT3 activity
relative to air-exposed STAT3+/+ mice. Plots show range and average ±
S.E.M. N = 10 in each group. p values shown, comparing both treatments
connected by a line. n.s. denotes no significant difference between groups.
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2.5% BSA for 1 h. After washing, the membranes were incubated
with Supersignal West Pico Luminol Enhancer Solution (Thermo
Scientific, Rockford, IL) and then imaged on a ChemiDoc XRS
Imaging System (BioRad).
STAT3 ACTIVITY
Lung nuclear protein from the lung tissue homogenates of
C57Bl/6J mice exposed to 1 day, 8 days, 7 weeks or 1 year of
cigarette smoke was used to determine STAT3 activity by con-
ducting an oligonucleotide-binding assay (ActiveMotif, Carlsbad,
CA). Of note, the lung tissue samples had undergone lung lavage
prior to measuring STAT3 activity. Results are presented as rel-
ative activity compared to controls (%), which is the reference
sample (usually room air treated STAT3+/+ mice).
CASPASE 3/7 ACTIVITY ASSAY
Caspase 3/7 activity was measured in the lung tissue whole
lysates of control and smoke-exposed STAT3+/+ and STAT3−/−
mice using the Caspase-Glo 3/7 Assay System (Promega,
Fitchburg, WI). Data is reported as relative luminescence
units (RLU). RLU is determined by analysis of signal
relative to background, using a Tecan Genios microplate
reader.
STATISTICAL ANALYSES
Data are expressed as means ± S.E.M. We determined statistical
significance by one-way analysis of variance for multiple group
analysis using GraphPad Prism Software (GraphPad, La Jolla,
CA). Student t-tests (two tailed) were used throughout the study.
All data sets are represented as range and mean ± standard error.
RESULTS
CIGARETTE SMOKE INDUCES STAT3 ACTIVATION IN MOUSE LUNGS
To determine the STAT3 response to cigarette smoke, STAT3
activity was measured in the nuclear fraction of the lungs of
C57Bl/6 mice subjected to varying periods of smoke exposure.
A 30% increase in STAT3 activation was observed as early as
one-day post cigarette smoke exposure (Figure 1). Moreover, 8
days exposure to cigarette smoke further activated STAT3 ∼5
fold. Maximal activation occurred after 7 weeks though increased
activity was observed up to 1 year of smoke exposure (Figure 1A).
It is conceivable that down regulation of IL-6 receptors or the
FIGURE 2 | STAT3 expression subdues BALF cellularity. Three-month old
STAT3+/+ and STAT3−/− mice were exposed to room air (white bars) or
cigarette smoke (black bars) for 4 h daily for 8 days. The mice were
euthanized 12 h post the last smoke exposure and (A) BALF cellularity was
measured by bright field microscopy. BALF macrophages and neutrophils
were determined by quick diff staining. (B) A typical representative
staining is shown here (Scale bar = 20μM). (C) qPCR for macrophage
marker CD68 also demonstrates higher levels of macrophages within the
lung tissue. Data are reported as BALF cells (x 10,000). Plots show range
and average ± S.E.M. N = 10 in each group. p values shown, comparing
both treatments connected by a line. n.s. denotes no significant difference
between groups.
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induction of protein inhibitor of activated STAT3 (PIAS3) may
have diminished the smoke-mediated induction of STAT3 at
the 1-year time point. However, this will need to be explored
in future studies. Together, these results show that cigarette
smoke causes a rapid and persistent activation of STAT3 in the
lung.
INCREASED INFLAMMATORY CELLS IN THE AIRWAYS OF STAT3−/−
MICE
Since cigarette smoke potently activated STAT3 in the lungs of
mice, we aimed to determine how the loss of STAT3 would
impact on smoke-mediated inflammatory responses. To address
this question, we exposed 129X1-Stat3tm1Desi/J (STAT3−/−) and
129X1/SvJ (STAT3+/+) mice to 8 days of cigarette smoke
exposure. Cigarette smoke increased STAT3 activity levels with
the lung of the STAT3+/+ after 8 days of smoke exposure
(Figure 1B). Cigarette smoke significantly increased BALF cellu-
larity in the lungs of the STAT3+/+ mice (26.8 ± 3.7 × 104 vs.
53.9 ± 13.3 × 104 cells for room air and smoke exposed, respec-
tively; p < 0.05) (Figure 2A). In comparison, the STAT3−/− mice
under room air conditions had significantly higher lung BALF cel-
lularity than STAT3+/+ mice (26.8 ± 3.7 × 104 vs. 48.2 ± 5.8 ×
104 cells for STAT3+/+ and STAT3−/−, respectively; p < 0.05).
In fact, the BALF cellularity of room air exposed STAT3−/−
mice was comparable to that of STAT3+/+ mice that had
been exposed to cigarette smoke for 8 days (Figure 2A). The
increase in BALF cells was primarily macrophages (Figure 2B).
Consistent with the increase in BALF cells that was measured
in the BALF, we found significantly higher expression of the
macrophage marker CD68 in the STAT3−/− mice under room
air conditions compared to the room air exposed STAT3+/+
mice (Figure 2C). Cigarette smoke exposure caused a two-fold
increase in BALF cellularity in the STAT3−/− mice compared
to room air exposed STAT3−/− mice (Figure 2A). This smoke-
mediated increase was proportional to that experienced by the
smoke-exposed STAT3+/+ mice though the STAT3+/+ had sig-
nificantly lower levels of inflammatory cells post exposure com-
pared to the STAT3−/− mice. Together, these findings show that
the lack of STAT3 activation alters immune cell infiltration in the
lung.
STAT3 EXPRESSION IMPACTS ON LUNG CYTOKINE AND PROTEASE
INDUCTION
Cigarette smoke induces the expression of pro inflammatory
cytokines and destructive proteases in the lung (Foronjy and
D’Armiento, 2001; Wright et al., 2002). For this reason, we eval-
uated how the loss of STAT3 altered lung cytokine and protease
expression in smoke-exposed mice. Under room air exposure
conditions, TNF-α BALF protein levels were significantly higher
in STAT3−/− mice than in STAT3+/+ mice (∼2-fold, p < 0.05)
(Figure 3). In response to cigarette smoke, IL-1α BALF protein
levels decreased in the STAT3+/+ mice (p < 0.05), but trended
higher in the STAT3−/− mice (Figure 3). In contrast, cigarette
smoke increased MCP-1 BALF protein levels in the STAT3−/−
mice, but not in the STAT3+/+ mice (Figure 3). STAT3 had
no effect on the smoke-mediated increase in IFN-γ and IL-
17 BALF protein expression and neither cigarette smoke nor
FIGURE 3 | STAT3 expression suppresses TNF-α, IL-1α, and MCP-1
BALF protein levels. Bioplex assays measured BALF cytokines in room air
and 8-day smoke-exposed STAT3+/+ and STAT3−/− mice. Data are reported
as cytokine level (pg/ml). Plots show range and average ± S.E.M. N = 10 in
each group. p values shown, comparing both treatments connected by a
line. n.s. denotes no significant difference between groups.
STAT3 expression altered RANTES or IL-6 BALF protein levels
(Figure 4). Of note, IL-10 has potent anti-inflammatory effects
in the lung (Mays et al., 2013) and BALF protein levels of the
anti-inflammatory cytokine IL-10 were significantly lower in the
STAT3−/− mice under room air conditions (Figure 4). We next
conducted quantitative PCR analyses to determine how STAT3
impacted on cytokine and protease expression within the lung
tissue of the mice. We found that KC was regulated both by
cigarette smoke exposure and STAT3 expression. Compared to
STAT3+/+ mice, the STAT3−/− mice had a ∼3-fold increase
in lung KC expression under room air conditions (Figure 5).
Furthermore, cigarette smoke induced a 2-fold increase in KC
expression in STAT3+/+ mice (p < 0.05), but a∼15-fold increase
in STAT3−/− mice (p < 0.05 vs. room air and vs. smoked
wild type; Figure 5). In terms of proteases, cigarette smoke
induced a ∼10-fold increase in MMP-10 lung mRNA expres-
sion (p < 0.01) in the STAT3+/+ mice but not in the smoke-
exposed STAT3−/− mice (Figure 5). Importantly, lung MMP-12
mRNA expression was upregulated ∼8-fold in the STAT3−/−
mice under room air conditions (p < 0.02). However, MMP-12
Frontiers in Physiology | Respiratory Physiology October 2013 | Volume 4 | Article 267 | 4
Geraghty et al. STAT3 regulates smoke-induced inflammation
FIGURE 4 | STAT3 expression impacts on IL-10 BALF protein levels.
Bioplex assays measured BALF cytokines (IFN-γ, IL-17, RANTES, IL-6, and
IL-10) in room air and 8-day smoke-exposed STAT3+/+ and STAT3−/− mice.
Data are reported as cytokine level (pg/ml). Plots show range and average ±
S.E.M. N = 10 in each group. p values shown, comparing both treatments
connected by a line. n.s. denotes no significant difference between groups.
expression was comparable in STAT3+/+ and STAT3−/− mice
following cigarette smoke exposure. Similarly, TNF-α, IL-1β,
and MCP-1 lung tissue expression were comparable in the
STAT3+/+ and STAT3−/− mice under smoke exposure conditions
(Figure 6).
LOSS OF STAT3 IMPACTS ON SOCS3 PROTEIN LEVELS IN THE LUNG
Suppressor of cytokine synthesis 3 (SOCS3) counters inflamma-
tion by blocking JAK and their associated receptors to limit the
duration and intensity of cytokine signaling (Babon and Nicola,
2012). Compared to STAT3+/+ mice, both SOCS3 protein expres-
sion was markedly lower in the STAT3−/− mice (Figure 7). Thus,
the loss of STAT3 expression may enhance lung inflammation
by diminishing the anti-inflammatory responses mediated by
SOCS3.
CASPASE 3/7 ACTIVITY IS INCREASED IN THE LUNGS OF THE
STAT3−/− MICE
Apoptosis is a critical process in the development of emphysema
(Tuder et al., 2003) and STAT3 regulates apoptotic responses
in vivo (Chapman et al., 2000; Abell et al., 2005). Thus, we
sought to determine how the loss of STAT3 expression impacted
on apoptotic responses in the lungs of smoke-exposed mice.
We measured caspase 3/7 activity, an important marker of
apoptosis (Albee et al., 2007), in the lungs of room air and 8-day
smoke-exposed STAT3+/+ and STAT3−/− mice. Cigarette smoke
induced a ∼20 fold increase in caspase 3/7 activity in the smoke-
exposed STAT3+/+ mice (p < 0.001) (Figure 8). Compared to
the STAT3+/+ mice, the STAT3−/− had a ∼10 fold increase in
caspase 3/7 activity at baseline (p < 0.01). However, the height-
ened activity did not increase further increase with cigarette
smoke exposure in STAT3−/− mice (Figure 8). STAT3 can reg-
ulate apoptosis by inducing the expression of the apoptotic
inhibitor Bcl-2 (Gao and Ward, 2007). Given this, immunoblots
for p-Bcl-2 and total Bcl-2 were conducted on lung tissue
lysates from control and 8-day smoke-exposed STAT3+/+ and
STAT3−/− mice. The expression of both p-Bcl-2 and total Bcl-2
showed a trend toward an increase in STAT3+/+ mice exposed to
smoke, while the trend was the opposite in the STAT3−/− mice
(Figure 9). However, the difference in p-Bcl-2 levels in the smoke
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exposed STAT3+/+ and STAT3−/− mice did not reach statistical
significance.
DISCUSSION
The role of STAT3 in inflammation is not clearly defined, with
evidence supporting STAT3 activation having pro-inflammatory
and anti-inflammatory roles (El Kasmi et al., 2006; Ruwanpura
et al., 2012). These varied effects may be due to disease- and
FIGURE 5 | Loss of lung STAT3 activity enhances gene expression of
MMP-10 and MMP-12. Quantitative PCR for mouse KC, MMP-10, and
MMP-12 was conducted on mRNA isolated from the lung tissue of room air
and 8-day smoke exposed STAT3+/+ and STAT3−/− mice using specific
Taqman probes. Data are reported as relative expression (RQ) to STAT3+/+
in room air conditions. Plots show range and average ± S.E.M. N = 10 in
each group. p values shown, comparing both treatments connected by a
line. n.s. denotes no significant difference between groups.
cell-specific mechanisms that determine the ultimate effect that
STAT3 exerts in a biological system. The expression of STAT3
and its downstream-related genes is significantly increased in
the lung tissue of COPD patients (Qu et al., 2009). This is sig-
nificant as STAT3 is known to regulate inflammation, protease
expression, and apoptosis (Li et al., 2011; Camporeale and Poli,
2012; Du et al., 2012), which are key biological processes in
the pathogenesis of COPD (Chung and Adcock, 2008). For this
reason, we sought to determine how the loss of STAT3 would
impact on these important disease parameters in the cigarette
smoke exposure model. This work shows for the first time that
STAT3−/− mice have enhanced inflammatory, proteolytic and
apoptotic responses in response to cigarette smoke. Furthermore,
the loss of STAT3 expression was associated with deficient anti-
inflammatory responses in these mice. STAT3 has been viewed
as a potential therapeutic target for the treatment of COPD
(Gao and Ward, 2007). However, these findings suggest that
STAT3 may have protective functions in the lung and inhibiting it
could exacerbate the underlying mechanisms involved in cigarette
smoke-induced lung diseases.
One of the most remarkable findings in the STAT3−/− mice
was the increased numbers of BALF cells, mostly macrophages,
under room air or smoke exposure conditions. Macrophages
are critical in COPD as these cells release proteases that induce
dysfunctional airway remodeling (Shapiro et al., 1991; Shapiro,
1999, 2003). This enhanced macrophage response may have been
due to the increased MCP-1 expression that was detected in
the STAT3−/− mice. MCP-1 is upregulated in COPD patients
(Bracke et al., 2007) and induces mucin production and lung
inflammation (de Boer et al., 2000; Monzon et al., 2011)
characterized by the influx of macrophages (Hautamaki et al.,
1997). It is somewhat surprising that the absence of STAT3
FIGURE 6 | STAT3 does not alter lung expression of TNF-α, IL-1β or
MCP-1. Quantitative PCR for mouse TNF-α, IL-1β or MCP-1 was conducted
on mRNA isolated from the lung tissue of room air and 8-day smoke exposed
STAT3+/+ and STAT3−/− mice using specific Taqman probes. Data are
reported as relative expression (RQ) to STAT3+/+ in room air conditions. Plots
show range and average ± S.E.M. N = 10 in each group. p values shown,
comparing both treatments connected by a line. n.s. denotes no significant
difference between groups.
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FIGURE 7 | STAT3 activity enhances lung SOCS-3 levels. Lungs from
STAT3+/+ and STAT3−/− mice exposed to room air or smoke for 8 days
were homogenized and SOCS3 and actin were detected by immunoblot.
Densitometry analysis was performed and results are represented as
SOCS3 protein relative to air-exposed STAT3+/+ mice. Actin levels were
also used to normalize protein loading and are reflected in graph shown
here.
FIGURE 8 | Loss of STAT3 expression increases lung Caspase 3/7
activity. Caspase 3/7 activity was measured from the lung tissue
homogenates of control and 8-day smoke exposed STAT3+/+ and STAT3−/−
mice using a specific luminescence assay (Promega). Data are reported as
relative luminescence units (RLU). Plots show range and average ± S.E.M.
N = 10 in each group. p values shown, comparing both treatments
connected by a line. n.s. denotes no significant difference between groups.
increased MCP-1 levels as several studies demonstrated that
MCP-1 expression is positively regulated by STAT3 (Burysek
et al., 2002; Chatterjee et al., 2009; Zhou et al., 2012). However,
the effect of STAT3 is likely influenced by the cell type and
physiologic context. Indeed, the loss of STAT3 expression in
FIGURE 9 | Loss of STAT3 gives a trend increase in smoke induced
Bcl-2 phosphorylation in mouse lungs. Lungs from STAT3+/+ and
STAT3−/− mice exposed to room air or smoke for 8 days were
homogenized and p-Bcl-2, Bcl-2, and actin were detected by immunoblot.
Each group had replicates of 3. Densitometry analysis was performed and
results are represented as p-Bcl-2 protein relative to air-exposed STAT3+/+
mice. Bcl-2 levels were also used to normalize protein loading and are
reflected in graph shown here.
macrophages enhanced inflammatory responses and increased
MCP-1 expression in thioglycollate-challenged mice (Matsukawa
et al., 2005).
In addition to the changes in MCP-1 expression, baseline
TNF-α levels were significantly increased in the STAT3−/− mice.
TNF-α, which is expressed by macrophages and other resident
lung cells, induces intracellular signaling events that promote the
development of emphysema (Riches et al., 1996; Churg et al.,
2004). Thus, our findings indicate that STAT3 expression can
impact on the disease by countering TNF-α expression in the
lung. Of note, STAT3 regulated BALF TNF-α protein levels but
not lung tissue TNF-α expression. This may indicate that STAT3
has a greater role on macrophage TNF-α expression than it does
on lung tissue TNF-α expression. In support of this, prior stud-
ies have shown that the induction of SOCS3 by STAT3 counters
TNF-α expression in macrophages (Berlato et al., 2002; Williams
et al., 2004). However, further studies will be needed to defini-
tively evaluate the effect of STAT3 within specific cell types in this
model.
In addition to TNF-α, STAT3 also deterred the smoke-
mediated induction of IL-1α in mice. This is significant as IL-1α
drives the influx of neutrophils in the lungs of COPD patients
(Botelho et al., 2011) and neutralizing IL-1α attenuates cigarette
smoke-induced inflammation in mice (Pauwels et al., 2011).
The enhanced inflammatory response in the STAT3−/− mice
was associated with increased MMP-12 expression. The fact that
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STAT3 negatively regulated MMP-12 is significant as this pro-
tease is upregulated in COPD patients (Demedts et al., 2006;
Ilumets et al., 2007) and plays a critical role in smoke-induced
emphysema in mice (Hautamaki et al., 1997). While the loss of
STAT3 increased MMP-12 expression, STAT3−/− mice had sig-
nificantly lower lung expression of MMP-10 following cigarette
smoke exposure. This is important as MMP-10 was found to
decrease inflammation in a mouse model of experimental coli-
tis (Koller et al., 2012). Thus, it is conceivable that the loss of
STAT3 expression can enhance lung inflammation by diminishing
MMP-10 expression in the lung.
The loss of STAT3 expression greatly impaired innate anti-
inflammatory responses in the lung. SOCS3 expression is posi-
tively regulated by STAT3 and, once activated, SOCS3 binds gp130
and inhibits Janus activated kinase (JAK) activity. Through this
mechanism, SOCS3 then modulates immune responses by down
regulating IL-1 and IL-6 signaling (Croker et al., 2003; Frobose
et al., 2006) and deterring MAPK activation (Puhr et al., 2010).
Thus, SOCS blocks key factors in the pathogenesis of COPD
(Mercer et al., 2004; Botelho et al., 2011). The loss of SOCS3
expression in macrophages causes a polarization into an M1 or
pro inflammatory phenotype (Qin et al., 2012a) and can enhance
cell death and apoptosis (Ruan et al., 2010; Qin et al., 2012b).
This may explain the increased macrophage levels and heightened
apoptotic responses observed in our study. Aside from SOCS3,
basal levels of the anti-inflammatory cytokine IL-10 were signifi-
cantly lower in the STAT3−/− mice. IL-10 is positively regulated
by STAT3 (Benkhart et al., 2000) and IL-10 deficiency renders the
lung more sensitive to pro inflammatory stimuli (Penttila et al.,
2008). Thus, we assert that the loss of STAT3 expression enhanced
susceptibility to smoke-induced inflammation by decreasing IL-
10 levels in the lung. Lastly, the STAT3−/− mice did not increase
MMP-10 expression in response to cigarette smoke exposure.
While most MMPs are believed to promote lung inflamma-
tion, MMP-10 exerts anti-inflammatory effects and promotes
repair responses following tissue injury (Rodriguez et al., 2008;
Koller et al., 2012). Together, these results show that the loss of
STAT3 expression causes deficient anti-inflammatory and repair
processes in mice.
There are several study limitations that merit discussion. For
one, constitutive STAT3−/− mice were utilized. STAT3 plays an
important role in myeloid cell maturation and differentiation
(Smithgall et al., 2000). Thus, the lack of STAT3 activation may
have altered the development of the immune system to render
the STAT3−/− mice more responsive to cigarette smoke expo-
sure. Moreover, since a whole body knockout was used the study
cannot address the effect of STAT3 loss specifically in the lung.
Lastly, though the loss of STAT3 exacerbated inflammation, pro-
tease expression and apoptosis, it is uncertain whether these
effects would have increased lung tissue destruction in the smoke-
exposed mice. Long-term smoke exposure studies and complete
morphological analyses are needed to address this question.
In summary, our findings show that STAT3 is activated by
cigarette smoke exposure, which may regulate key inflammatory,
proteolytic and apoptotic responses in the lung. STAT3 medi-
ates these effects at least in part by modulating anti-inflammatory
responses such as SOCS3 and IL-10 expression in the lung. Future
studies are needed to address the role of STAT3 in the disease
to determine whether targeting STAT3 activity could be used as
an approach to counter the injurious effects of cigarette smoke
exposure in the lung.
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